Fine particulate air pollution, nitrogen dioxide, and systemic autoimmune rheumatic disease in Calgary, Alberta

Environmental Research

Volumn 140, Issue , 2015, Pages 474-478

  Bernatsky, Sasha ^a,b   Smargiassi, Audrey ^b,c,d   Johnson, Markey ^b,e   Kaplan, Gilaad G ^b,f   Barnabe, Cheryl ^b,f,g,h   Svenson, Larry ^b,f,g,h   Brand, Allan ^b,c,d   Bertazzon, Stefania ^b,i   Hudson, Marie ^a,b,j   Clarke, Ann E ^a,b   Fortin, Paul R ^b,k   Edworthy, Steven ^b,f,g,h   Bélisle, Patrick ^b   Joseph, Lawrence ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

^e HEALTH CANADA   (Canada)

^f UNIVERSITY OF CALGARY   (Canada)

^g MINISTRY OF HEALTH   (Canada)

^h UNIVERSITY OF ALBERTA   (Canada)

ⁱ UNIVERSITY OF CALGARY   (Canada)

^j MCGILL UNIVERSITY   (Canada)

^k UNIVERSITÉ LAVAL   (Canada)

more..

Author keywords

Air pollution; Systemic autoimmune rheumatic diseases

Indexed keywords

NITROGEN DIOXIDE; PARTICULATE MATTER;

ABNORMALITY; AMBIENT AIR; ATMOSPHERIC POLLUTION; HEALTH RISK; HEALTH STATUS; IMMUNE RESPONSE; LAND USE; NITROGEN DIOXIDE; PARTICULATE MATTER; POLLUTION EXPOSURE; PROBABILITY; REGRESSION ANALYSIS; RESIDENT POPULATION; SPATIOTEMPORAL ANALYSIS;

ADULT; AGE; AIR POLLUTION; AMBIENT AIR; ARTICLE; BAYESIAN LEARNING; CANADA; FEMALE; FIRST NATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PARTICULATE MATTER; PREVALENCE; PRIORITY JOURNAL; PROBABILITY; RHEUMATIC DISEASE; SEX DIFFERENCE; SYSTEMIC AUTOIMMUNE RHEUMATIC DISEASE; URBAN POPULATION; AUTOIMMUNE DISEASE; CHEMICALLY INDUCED; MIDDLE AGED; TOXICITY;

ALBERTA; CALGARY; CANADA;

ALBERTA; AUTOIMMUNE DISEASES; FEMALE; HUMANS; MALE; MIDDLE AGED; NITROGEN DIOXIDE; PARTICULATE MATTER; RHEUMATIC DISEASES;

EID: 84930934687     PISSN: 00139351     EISSN: 10960953     Source Type: Journal    
DOI: 10.1016/j.envres.2015.05.007     Document Type: Article

References (38)

1. Aghdassi E., Zhang W., St-Pierre Y., Clarke A.E., Morrison S., Peeva V., et al. Healthcare cost and loss of productivity in a Canadian population of patients with and without lupus nephritis. J. Rheumatol. 2011, 38(4):658-666.
2. Alberta Health and Wellness, 2004. First Nations health services study technical documentation. (cited 04.01.14.). http://www.health.alberta.ca/documents/First-Nation-Service-Use-2004.pdf.
3. Anderson J.O., Thundiyil J.G., Stolbach A. Clearing the air: a review of the effects of particulate matter air pollution on human health. J. Med. Toxicol. 2012, 8(2):166-175.
4. Ballestar E. Epigenetics lessons from twins: prospects for autoimmune disease. Clin. Rev. Allergy Immunol. 2010, 39(1):30-41.
5. Barnabe C., Joseph L., Belisle P., Labrecque J., Edworthy S., Barr S.G., et al. Prevalence of systemic lupus erythematosus and systemic sclerosis in the First Nations population of Alberta, Canada. Arthritis Care Res. 2012, 64(1):138-143.
6. Beratazzon, S., Elikan, O., Johnson, M., Bertazzon, S., Elikan,O., Johnson, M., 2011. Geographically weighted land use regression to model air pollution and its health effects. In: Proceedings of the European Colloquium on Quantitative and Theoretical Geography (ECQTG), 2-6 September, Athens, Greece.
7. Bernatsky S., Smargiassi A., Barnabe C., Svenson L., et al. Fine particulate air pollution and systemic autoimmune rheumatic disease in Alberta [Abstract]. J. Rheumatol. 2014, (Supplement).
8. Bernatsky S., Joseph L., Belisle P., Boivin J.F., Rajan R., Moore A., et al. Bayesian modelling of imperfect ascertainment methods in cancer studies. Stat. Med. 2005, 24(15):2365-2379.
9. Bernatsky S., Hudson M., Panopalis P., Clarke A.E., Pope J., LeClercq S., et al. The cost of systemic sclerosis. Arthritis Rheumatol. 2009, 61(1):119-123.
10. Bernatsky S., Fournier M., Pineau C.A., Clarke A.E., Vinet E., Smargiassi A. Associations between ambient fine particulate levels and disease activity in patients with systemic lupus erythematosus (SLE). Environ. Health Perspect. 2011, 119(1):45-49.
11. Broten L., Avina-Zubieta J.A., Lacaille D., Joseph L., Hanly J.G., Lix L., et al. Systemic autoimmune rheumatic disease prevalence in Canada: updated analyses across 7 provinces. J. Rheumatol. 2014, 41(4):673-679.
12. Cai J., Zhao A., Zhao J., Chen R., Wang W., Ha S., et al. Acute effects of air pollution on asthma hospitalization in Shanghai, China. Environ. Pollut. 2014, 191:139-144.
13. Callaghan R., Prabu A., Allan R.B., Clarke A.E., Sutcliffe N., Pierre Y., et al. Direct healthcare costs and predictors of costs in patients with primary Sjogren's syndrome. Rheumatology 2007, 46(1):105-111.
14. Chen H., Burnett R.T., Kwong J.C., Villeneuve P.J., Goldberg M.S., Brook R.D., et al. Risk of incident diabetes in relation to long-term exposure to fine particulate matter in Ontario, Canada. Environ. Health Perspect. 2013, 121(7):804-810.
15. Cooper G.S., Stroehla B.C. The epidemiology of autoimmune diseases. Autoimmun. Rev. 2003, 2(3):119-125.
16. Cooper G.S., Germolec D., Heindel J., Selgrade M. Linking environmental agents and autoimmune diseases. Environ. Health Perspect. 1999, 107(Suppl. 5):S659-S660.
17. De Roos A.J., Koehoorn M., Tamburic L., Davies H.W., Brauer M. Proximity to traffic, ambient air pollution, and community noise in relation to incident rheumatoid arthritis. Environ. Health Perspect. 2014, 122(10):1075-1080. 10.1289/ehp.1307413.
18. Elikan, O., Underwood, F., Azad, A.K., Bertazzon, S., Kaplan, G., Johnson, M, 2011. Land use regression modelling of air pollution in Calgary. In: Proceedings of the Canadian Association of Geographers and Canadian Cartographic Association Conference, May 31-June 4, Calgary, Alberta.
19. Eze I.C., Schaffner E., Fischer E., Schikowski T., Adam M., Imboden M., et al. Long-term air pollution exposure and diabetes in a population-based Swiss cohort. Environ. Int. 2014, 70:95-105.
20. Farhat S.C., Silva C.A., Orione M.A., Campos L.M., Sallum A.M., Braga A.L. Air pollution in autoimmune rheumatic diseases: a review. Autoimmun. Rev. 2011, 11:14-21.
21. Hart J.E., Laden F., Puett R.C., Costenbader K.H., Karlson E.W. Exposure to traffic pollution and increased risk of rheumatoid arthritis. Environ. Health Perspect. 2009, 117(7):1065-1069.
22. Hart J.E., Kallberg H., Laden F., Costenbader K.H., Yanosky J.D., Klareskog L., et al. Ambient air pollution exposures and risk of rheumatoid arthritis. Arthritis Care Res. 2013, 65(7):1190-1196.
23. Hart J.E., Kallberg H., Laden F., Bellander T., Costenbader K.H., Holmqvist M., et al. Ambient air pollution exposures and risk of rheumatoid arthritis: results from the Swedish EIRA case-control study. Ann. Rheum. Dis. 2013, 72(6):888-894.
24. Health Effects Institute, 2010. Traffic-Related Air Pollution: A Critical Review of the Literature on Emissions, Exposure, and Health Effects. Special Report #17. (cited 30.04.14.). http://www/pubs%20healtheffects%20org/view%20php?id=334.
25. Johnson M., Macneill M., Grgicak-Mannion A., Nethery E., Xu X., Dales R., et al. Development of temporally refined land-use regression models predicting daily household-level air pollution in a panel study of lung function among asthmatic children. J. Expo. Sci. Environ. Epidemiol. 2013, 23(3):259-267.
26. Labrecque J. Estimating Health-Selective Migration in Patients With Systemic Lupus Erythematosus or Sjogren's From Administrative Data (Ph.D. thesis) 2013, McGill University, Canada.
27. Labrecque J., Smargiassi A., Joseph L., Hudson M., Fortin P., Bernatsky S. Road density and SARD prevalence. J. Rheumatol. 2010, 134S.
28. Mastrofrancesco A., Alfe M., Rosato E., Gargiulo V., Beatrice C., Di B.G., et al. Proinflammatory effects of diesel exhaust nanoparticles on scleroderma skin cells. J. Immunol. Res. 2014, 2014:138751.
29. Panopalis P., Petri M., Manzi S., Isenberg D.A., Gordon C., Senecal J.L., et al. The systemic lupus erythematosus Tri-Nation study: cumulative indirect costs. Arthritis Rheumatol. 2007, 57(1):64-70.
30. Prosser R.J., Carleton B.C., Smith M.A. Identifying persons with treated asthma using administrative data via latent class modelling. Health Serv. Res. 2008, 43(2):733-754.
31. Ryan P.H., LeMasters G.K. A review of land-use regression models for characterizing intraurban air pollution exposure. Inhal. Toxicol. 2007, 19(Suppl. 1):S127-S133.
32. Shapira Y., Agmon-Levin N., Shoenfeld Y. Defining and analyzing geoepidemiology and human autoimmunity. J. Autoimmun. 2010, 34(3):J168-J177.
33. Valesini G., Gerardi M.C., Lannuccelli C., Pacucci V.A., Pendolino M. Shoenfeld Citrullination and autoimmunity. Autoimmun. Rev. 2015, (Epub ahead of print).
34. van Eeden S.F., Leipsic J., Paul Man S.F., Sin D.D. The relationship between lung inflammation and cardiovascular disease. Am. J. Respir. Crit. Care Med. 2012, 186(1):11-16.
35. van Eeden S.F., Tan W.C., Suwa T., Mukae H., Terashima T., Fujii T., et al. Cytokines involved in the systemic inflammatory response induced by exposure to particulate matter air pollutants (PM(10)). Am. J. Respir. Crit. Care Med. 2001, 164(5):826-830.
36. Wood, J., 2012. Canadian Environmental Indicators - Air Quality. The Fraser Institute: Studies in Environmental Policy.
37. Zeft A.S., Prahalad S., Lefevre S., Clifford B., McNally B., Bohnsack B.F., et al. Juvenile idiopathic arthritis and exposure to fine particulate air pollution. Clin. Exp. Rheumatol. 2009, 27(5):877-884.
38. Zhao A., Chen R., Kuang X., Kan H. Ambient air pollution and daily outpatient visits for cardiac arrhythmia in Shanghai, China. J. Epidemiol. 2014, 24(4):321-326.